15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 7 firms covering Addus HomeCare Corporation, 5 rate it Buy or better, 1 sit at Hold, and 1 rate it Sell or worse, a moderate buy consensus. Targets span $96.00 to $145.00, a moderate spread. The average target of $131.00 sits 10% above the current $119.13. The rating mix has stayed broadly stable, with Buy-side ratings easing from 6 to 5 over recent months. On the fundamentals, the Street sees revenue growth near 7% this year and 5% next, consensus EPS building from about $1.76 next quarter toward $7.48 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS7 ratings
Moderate Buy
Strong Buy00%
Buy571%
Hold114%
Sell114%
Strong Sell00%
Based on 7 analysts giving stock ratings to Addus HomeCare Corporation.
As of Jul, 5 of 7 firms rate ADUS a Buy (1 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
ADUS EPS & revenue forecast
EPS · NEXT QUARTER
$1.76
Range $1.68 – $1.84 · 14 analysts · +13% YoY
Next period, 14 analysts expect Addus HomeCare Corporation to earn $1.76 a share (range $1.68 – $1.84), versus $1.56 a year earlier. Full-year consensus is $7.00, growing to $7.48 the year after.
REVENUE · NEXT QUARTER
$386.7M
Range $377.2M – $391.9M · 14 analysts · +7% YoY
Revenue is expected to reach $386.7M (range $377.2M – $391.9M), +7.0% year-over-year. Full-year consensus is $1.5B, rising to $1.6B next year.
Top analysts covering Addus HomeCare Corporation
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on ADUS.
#1
Tao Qiu
Macquarie · Rank #112
Buy
$133.00+11.6% to target
Overall win rate
42%
+ Follow
#2
Ben Hendrix
RBC Capital · Rank #117
Buy
$130.00+9.1% to target
Overall win rate
44%
+ Follow
#3
Constantine Davides
JMP Securities · Rank #225
Buy
$142.00+19.2% to target
Overall win rate
34%
+ Follow
#4
Nicholas Jones
JMP Securities · Rank #255
Buy
$150.00+25.9% to target
Overall win rate
34%
+ Follow
#5
Jim Salera
Stephens & Co. · Rank #377
Buy
$135.00+13.3% to target
Overall win rate
20%
+ Follow
ADUS stock forecast FAQ
What is ADUS's average 12-month price target?+
The 7 analysts with a live target average $131.00 for Addus HomeCare Corporation over the next 12 months, ranging from a $145.00 high to a $96.00 low.
Is ADUS stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 7 analyst ratings, 5 are Buy or Strong Buy, 1 are Hold, and 1 are Sell or Strong Sell.
What are the highest and lowest price targets for ADUS?+
The Street-high target is $145.00 (UBS), and the Street-low is $96.00 (Barclays). The average of all 7 active targets is $131.00.
How many Wall Street analysts cover ADUS?+
7 analysts have an active rating on Addus HomeCare Corporation, and 7 firms carry a live 12-month price target.
Who is the most accurate analyst covering ADUS?+
Among analysts who currently cover ADUS, Tao Qiu of Macquarie has the strongest overall Quantellect track record (Rank #112). Their current call is Buy with a $133.00 target.
What is Addus HomeCare Corporation's projected EPS for next quarter?+
The consensus estimate is $1.76 per share (range $1.68 – $1.84) across 14 analysts. Full-year EPS is projected at $7.00, rising to $7.48 the following year.
How much revenue is Addus HomeCare Corporation expected to report next quarter?+
Consensus revenue is $386.7M (range $377.2M – $391.9M). Full-year revenue is projected at $1.5B, growing to $1.6B next year.
Have analysts been upgrading or downgrading ADUS lately?+
As of Jul, 5 of 7 firms rate ADUS a Buy (1 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their ADUS calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
